News

The US–China semiconductor dispute has entered a new phase of escalation, with the US Department of Commerce adding 23 ...
Objectives The development of simple tools to identify individuals at high risk of coronary heart disease (CHD) would enable rapid implementation of preventive measures. This study was designed to ...
China’s biggest chipmaker is testing the country’s first advanced locally made chipmaking machines. The move shows progress ...
The United States on Friday penalized two Chinese firms that acquired U.S. chipmaking equipment for China's top chipmaker ...
Shares of Chinese analog chip vendors rose sharply after Beijing launched probes into the U.S. semiconductor sector, boosting hopes for local chip makers to gain market share.
SEMICON Taiwan 2025 gathered a wide range of packaging and test equipment suppliers, all unveiling their latest technologies ...
The FDA has approved the Idylla CDx MSI test — a fully automated, “sample-to-result” companion diagnostic — for patients with colorectal cancer, according to a press release.The test, developed by ...
Biocartis Group NV received premarket approval from the U.S. FDA for its Idylla Cdx MSI test, developed in partnership with Bristol Myers Squibb Co., to help in the diagnosis and treatment of ...
BEIJING -- A remote-handling test platform of China's Comprehensive Research Facility for Fusion Technology (CRAFT) has ...
The National Medical Products Administration said on Monday that it has recently released China's first standard for brain-computer interface medical devices, paving the way for high-quality growth of ...
Chinese chipmaking stocks ticked higher on Monday after Beijing launched an anti-dumping investigation targeting certain U.S.